Trials / Completed
CompletedNCT07100964
A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Nerandomilast in the Blood
The Effect of Multiple Oral Doses of Carbamazepine on the Single-oral-dose Pharmacokinetics of Nerandomilast in Healthy Male Trial Participants (an Open-label, Two-treatment, Two- Period Fixed Sequence Trial)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the effect of carbamazepine on pharmacokinetics of nerandomilast.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | nerandomilast | nerandomilast |
| DRUG | carbamazepine | carbamazepine |
Timeline
- Start date
- 2025-08-11
- Primary completion
- 2025-09-20
- Completion
- 2025-10-01
- First posted
- 2025-08-03
- Last updated
- 2025-10-14
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT07100964. Inclusion in this directory is not an endorsement.